EDIT stock forecast
Our latest prediction for Editas Medicine Inc's stock price was made on the June 8, 2023 when the stock price was at 9.60$.
In the short term (2weeks), EDIT's stock price should underperform the market by -2.07%. During that period the price should oscillate between -7.78% and +4.72%.
In the medium term (3months), EDIT's stock price should underperform the market by -5.08%. During that period the price should oscillate between -29.17% and +17.77%.
Get email alertsCreate a solid portfolio with EDIT
About Editas Medicine Inc
unlocking the promise of genome editing to deliver life-changing medicines. editas medicine's mission is to translate its genome editing technology into a novel class of human therapeutics that enable precise and corrective molecular modification to treat the underlying cause of a broad range of diseases at the genetic level.
At the moment the company generates 197M USD in revenues.
On its last earning announcement, the company reported a loss of -3.18$ per share.
The book value per share is 4.84$
Three months stock forecastJune 8, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
197M | 11.53% | -226M | -114.46% | -155M | -3.18 | - | - | 68M | 4.84 | - | - | - |